Team:Grenoble-EMSE-LSU/Project/Biology

From 2013.igem.org

(Difference between revisions)
Line 66: Line 66:
<li>
<li>
<h2>Construction of pLac-RBS-KillerRed and pLac-RBS-mCherry</h2>
<h2>Construction of pLac-RBS-KillerRed and pLac-RBS-mCherry</h2>
-
<p>The KillerRed gene that we obtained initially was in an eukaryotic plasmid. To express KillerRed in <em>E. coli</em> and characterize its effects in response to light stimulations, we decided to clone KillerRed into the commercial prokaryotic expression vector pQE30 (Qiagen). This plasmid contains a pLac promoter and a Shine-Dalgarno Ribosome Binding Site (RBS) that allow gene expression in response to the presence of Isopropyl β-D-1-thiogalactopyranoside (IPTG). The pLac-RBS-KillerRed sequence in the pQE30 vector has been submitted as BBa_K1141001. Furthermore, the pLac-RBS-KillerRed sequence was cloned into the pSB1C3 plasmid, to give the biobrick BBa_K1141002. Both BBa_K1141001 and BBa_K1141002 were sent to the standard registry part (Fig 3.).<br><br>
+
<p>The KillerRed gene that we obtained initially was in an eukaryotic plasmid. To express KillerRed in <em>E. coli</em> and characterize its effects in response to light stimulations, we decided to clone KillerRed into the commercial prokaryotic expression vector pQE30 (Qiagen). This plasmid contains a pLac promoter and a Shine-Dalgarno Ribosome Binding Site (RBS) that allow gene expression in response to the presence of Isopropyl β-D-1-thiogalactopyranoside (IPTG). The pLac-RBS-KillerRed sequence in the pQE30 vector has been submitted as <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141001</a>. Furthermore, the pLac-RBS-KillerRed sequence was cloned into the pSB1C3 plasmid, to give the biobrick <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141002</a>. Both <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141001</a> and <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141002</a> were sent to the standard registry part (Fig 3.).<br><br>
-
                                         The choice of an inducible promoter is linked to the absence of literature about the effects of KillerRed on cells in low light. Since KillerRed could be cytotoxic and prevent bacteria from growing even at low doses of light, we wanted to be able to control its intracellular concentration. A negative control for KillerRed characterization was also required. We decided to use the fluorescent protein mCherry, which displays the same excitation and emission spectra as KillerRed <a href="#ref_bio_1">[4]</a>, and was shown not to be cytotoxic upon light illumination <a href="#ref_bio_1">[5]</a>. pSB1C3::pLac-RBS-mCherry (BBa_K1141000) was thus constructed from the existing biobricks BBa_R0010 and BBa_J06702 (Fig 3.).<br><br></p>
+
                                         The choice of an inducible promoter is linked to the absence of literature about the effects of KillerRed on cells in low light. Since KillerRed could be cytotoxic and prevent bacteria from growing even at low doses of light, we wanted to be able to control its intracellular concentration. A negative control for KillerRed characterization was also required. We decided to use the fluorescent protein mCherry, which displays the same excitation and emission spectra as KillerRed <a href="#ref_bio_1">[4]</a>, and was shown not to be cytotoxic upon light illumination <a href="#ref_bio_1">[5]</a>. pSB1C3::pLac-RBS-mCherry <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141000</a> was thus constructed from the existing biobricks BBa_R0010 and BBa_J06702 (Fig 3.).<br><br></p>
                                         <p align="center"><img src="https://static.igem.org/mediawiki/2013/0/00/Grenoble_Biobricks_KR_and_mCherry.png" alt="biobricks" width="75%"></p>
                                         <p align="center"><img src="https://static.igem.org/mediawiki/2013/0/00/Grenoble_Biobricks_KR_and_mCherry.png" alt="biobricks" width="75%"></p>
-
                                         <p id="legend">Figure 3.<br>Biobricks BBa_K1141002 <em>(A)</em> and BBa_K1141000 <em>(B)</em> used for characterizing KillerRed. <em>(C)</em> Picture showing a pellet of KillerRed-expressing bacteria.</p>
+
                                         <p id="legend">Figure 3.<br>Biobricks <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141002</a> <em>(A)</em> and <a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141000</a> <em>(B)</em> used for characterizing KillerRed. <em>(C)</em> Picture showing a pellet of KillerRed-expressing bacteria.</p>
</li>
</li>
Line 98: Line 98:
                                         <h4 id="iptg_induction">IPTG induction</h4>
                                         <h4 id="iptg_induction">IPTG induction</h4>
                                         <p>One important point for our project was to reach a high level of KillerRed expression, without slowing down cellular growth. As a matter of fact, to increase or decrease the amount of viable cells in our culture, we needed to make sure that the bacteria expressing KillerRed could grow in the dark and be killed in response to light stimulations. Now, the more KillerRed is present inside bacteria, the more ROS are produced upon illumination and the more likely the cells are to die. But is bacterial growth affected by high intracellular concentrations of KillerRed? Is there an optimal IPTG concentration to reach high levels of KillerRed without disturbing cell division?<br><br>
                                         <p>One important point for our project was to reach a high level of KillerRed expression, without slowing down cellular growth. As a matter of fact, to increase or decrease the amount of viable cells in our culture, we needed to make sure that the bacteria expressing KillerRed could grow in the dark and be killed in response to light stimulations. Now, the more KillerRed is present inside bacteria, the more ROS are produced upon illumination and the more likely the cells are to die. But is bacterial growth affected by high intracellular concentrations of KillerRed? Is there an optimal IPTG concentration to reach high levels of KillerRed without disturbing cell division?<br><br>
-
                                         To answer these questions, we decided to induce KillerRed expression with different concentrations of IPTG, while monitoring OD610 and fluorescence. M15 cells transformed with pSB1C3::pLac-RBS-mCherry (BBa_K1141000) were used as a negative control. To evaluate the amount of KillerRed proteins per living cell, we normalized fluorescence by optical density. Results are shown in Fig 6.<br><br></p>
+
                                         To answer these questions, we decided to induce KillerRed expression with different concentrations of IPTG, while monitoring OD610 and fluorescence. M15 cells transformed with pSB1C3::pLac-RBS-mCherry (<a href="/Team:Grenoble-EMSE-LSU/Documentation/Biobricks">BBa_K1141000</a>) were used as a negative control. To evaluate the amount of KillerRed proteins per living cell, we normalized fluorescence by optical density. Results are shown in Fig 6.<br><br></p>
                                         <p align="center"><img src="https://static.igem.org/mediawiki/2013/4/41/Grenoble_Growth_mCherry_vs_KR.png" alt="mCherry vs KillerRed" height="450px"></p>
                                         <p align="center"><img src="https://static.igem.org/mediawiki/2013/4/41/Grenoble_Growth_mCherry_vs_KR.png" alt="mCherry vs KillerRed" height="450px"></p>

Revision as of 02:15, 5 October 2013

Grenoble-EMSE-LSU, iGEM


Grenoble-EMSE-LSU, iGEM

Retrieved from "http://2013.igem.org/Team:Grenoble-EMSE-LSU/Project/Biology"